Fei Li

Mengying Yuan, Wenhao Wang, Zixuan Wang et al.

Natural Language Inference (NLI) is a fundamental task in natural language processing. While NLI has developed many sub-directions such as sentence-level NLI, document-level NLI and cross-lingual NLI, Cross-Document Cross-Lingual NLI (CDCL-NLI) remains largely unexplored. In this paper, we propose a novel paradigm: CDCL-NLI, which extends traditional NLI capabilities to multi-document, multilingual scenarios. To support this task, we construct a high-quality CDCL-NLI dataset including 25,410 instances and spanning 26 languages. To address the limitations of previous methods on CDCL-NLI task, we further propose an innovative method that integrates RST-enhanced graph fusion with interpretability-aware prediction. Our approach leverages RST (Rhetorical Structure Theory) within heterogeneous graph neural networks for cross-document context modeling, and employs a structure-aware semantic alignment based on lexical chains for cross-lingual understanding. For NLI interpretability, we develop an EDU (Elementary Discourse Unit)-level attribution framework that produces extractive explanations. Extensive experiments demonstrate our approach's superior performance, achieving significant improvements over both conventional NLI models as well as large language models. Our work sheds light on the study of NLI and will bring research interest on cross-document cross-lingual context understanding, hallucination elimination and interpretability inference. Our code and datasets are available at "https://github.com/Leonardo123-ui/CDCL_NLI" for peer review.

Xiaoqi Wang, Yingjie Cheng, Yaning Yang et al.

Self-supervised representation learning (SSL) on biomedical networks provides new opportunities for drug discovery. However, how to effectively combine multiple SSL models is still challenging and has been rarely explored. Therefore, we propose multi-task joint strategies of self-supervised representation learning on biomedical networks for drug discovery, named MSSL2drug. We design six basic SSL tasks inspired by various modality features including structures, semantics, and attributes in heterogeneous biomedical networks. Importantly, fifteen combinations of multiple tasks are evaluated by a graph attention-based multi-task adversarial learning framework in two drug discovery scenarios. The results suggest two important findings. (1) Combinations of multimodal tasks achieve the best performance compared to other multi-task joint models. (2) The local-global combination models yield higher performance than random two-task combinations when there are the same size of modalities. Therefore, we conjecture that the multimodal and local-global combination strategies can be treated as the guideline of multi-task SSL for drug discovery.